AU4226601A - Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases - Google Patents

Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases

Info

Publication number
AU4226601A
AU4226601A AU42266/01A AU4226601A AU4226601A AU 4226601 A AU4226601 A AU 4226601A AU 42266/01 A AU42266/01 A AU 42266/01A AU 4226601 A AU4226601 A AU 4226601A AU 4226601 A AU4226601 A AU 4226601A
Authority
AU
Australia
Prior art keywords
thiazolidin
methyl
dicarboxylic acid
infectious diseases
treating infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42266/01A
Inventor
Hans Rommelspacher
Rudy Susilo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4226601A publication Critical patent/AU4226601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

The aim of the invention is to provide a physiologically very compatible substance for treating infections with retroviruses and especially, infections with HI-viruses, with less side effects than the substances so far provided by the prior art. To this end, the invention uses 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof.
AU42266/01A 2000-02-15 2001-02-15 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases Abandoned AU4226601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10008050 2000-02-15
DE10008050A DE10008050A1 (en) 2000-02-15 2000-02-15 Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid for the treatment of infectious diseases
PCT/DE2001/000655 WO2001060342A2 (en) 2000-02-15 2001-02-15 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases

Publications (1)

Publication Number Publication Date
AU4226601A true AU4226601A (en) 2001-08-27

Family

ID=7631836

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42266/01A Abandoned AU4226601A (en) 2000-02-15 2001-02-15 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases

Country Status (6)

Country Link
EP (1) EP1257274B1 (en)
AT (1) ATE266403T1 (en)
AU (1) AU4226601A (en)
DE (2) DE10008050A1 (en)
ES (1) ES2221641T3 (en)
WO (1) WO2001060342A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711052C2 (en) * 1997-03-03 1999-09-23 Hans Rommelspacher Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid as a mucolytic
DE19711053C2 (en) * 1997-03-03 1999-09-02 Rommelspacher Combination preparation of 2-methyl-thiazolidine-2,4-dicarboxylic acid and paracetamol

Also Published As

Publication number Publication date
DE10008050A1 (en) 2001-08-23
WO2001060342A3 (en) 2002-03-28
EP1257274A2 (en) 2002-11-20
ES2221641T3 (en) 2005-01-01
DE50102262D1 (en) 2004-06-17
ATE266403T1 (en) 2004-05-15
WO2001060342A2 (en) 2001-08-23
EP1257274B1 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
NZ515392A (en) Respiratory syncytial virus replication inhibitors
TR200302214T4 (en) Pteridine compounds used for the treatment of psoriasis
SE0200979D0 (en) New compounds
WO2002011764A3 (en) Pharmaceutical compositions
RS50140B (en) Percyquinnin, a process for its production, and its use as a pharmaceutical
SE0100901D0 (en) New composition
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU2002215932A1 (en) Nitroderivatives as drugs for diseases having an inflammatory basis
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
AU2001266575A1 (en) Chemical compounds
AU2002221908A1 (en) Novel use of protein hydrolysates
BR0011700A (en) Dinitriles of arylmalonic acid substituted as intermediates for the preparation of herbicides
ATE464878T1 (en) PHARMACEUTICAL COMPOSITION FOR NASAL USE OF FENTANYL
CY1105317T1 (en) USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE
CY1105142T1 (en) USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE
DE60128100D1 (en) ANALGICAL DRUG
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
WO2001060343A3 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
AU4226601A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases
SE0000303D0 (en) Novel compounds
AU2003256108A1 (en) Organic acid salt of amlodipine
UY27372A1 (en) DERIVATIVES OF BENCIMIDAZOL 1-ARIL-2-N, S OR O-SUBSTITUTES, ITS USE FOR THE OBTAINING OF PHARMACEUTICAL DRUGS AND PREPARATIONS CONTAINING THESE DERIVATIVES
SE0102058D0 (en) New Salts II

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase